GL1X · GenesisL1 explorer

UniProt Q9P289

Q9P289

Q9P289 (UniProt Q9P289): 16 experimental structures on GenesisL1, 2 ligands bound. Binding sites, pockets, druggability and 3D structures in GL1X.

UniProt
Q9P289
Experimental structures
16
Predicted models
0
Ligands
2

Structures

16 records of Q9P289 in the MolNFT archive: 16 experimental, 0 predicted.

EntryTitleMethodChainsLigandsPockets
3GGFCrystal structure of human Serine/threonine-protein kinase MST4 in complex with an quinazolinx-ray diffractionA, B——
3GGFCrystal structure of human SERINE/THREONINE-protein kinase MST4 in complex with an quinazolinx-ray diffractionA, B——
3W8ICrystal structure of CCM3 in complex with the C-terminal regulatory domain of MST4x-ray diffractionB——
3W8ICrystal structure of CCM3 in complex with the C-terminal regulatory domain of MST4x-ray diffractionB——
4FZACrystal structure of MST4-MO25 complexx-ray diffractionB——
4FZACrystal structure of MST4-MO25 complexx-ray diffractionB——
4FZDCrystal structure of MST4-MO25 complex with WSF motifx-ray diffractionB, C——
4FZDCrystal structure of MST4-MO25 complex with wsf motifx-ray diffractionB, C——
4FZFCrystal structure of MST4-MO25 complex with DKIx-ray diffractionB——
4FZFCrystal structure of MST4-MO25 complex with dkix-ray diffractionB——
4GEHCrystal structure of MST4 dimerization domain complex with PDCD10x-ray diffractionB, D——
4GEHCrystal structure of MST4 dimerization domain complex with PDCD10x-ray diffractionB, D——
5XY9Structure of the MST4 and 14-3-3 complexx-ray diffractionC, D——
5YF4A kinase complex MST4-MOB4x-ray diffractionB——
7B36MST4 in complex with compound G-5555x-ray diffractionA, C59T, CL—
Q9P289AlphaFold monomer V2.0 prediction for SERINE/THREONINE-protein kinase 26 (Q9P289)———

Ligands

  • 59T · 8-[(trans-5-amino-1,3-dioxan-2-yl)methyl]-6-[2-chloro-4-(6-methylpyridin-2-yl)phenyl]-2-(methylamino) pyrido[2,3-d]pyrimidin-7(8H)-one · in 1 record
  • CL · Chloride ion · in 1 record

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.